{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T01:19:21Z","timestamp":1793063961205,"version":"4.5.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajconline.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Cardiology"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1016\/j.amjcard.2019.08.018","type":"journal-article","created":{"date-parts":[[2019,8,23]],"date-time":"2019-08-23T11:13:54Z","timestamp":1566558834000},"page":"1554-1560","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"title":["Prevalence and Incidence of Atrial Fibrillation in Ambulatory Patients With Heart Failure"],"prefix":"10.1016","volume":"124","author":[{"given":"Pierpaolo","family":"Pellicori","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessia","family":"Urbinati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuldeep","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jufen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parin","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Syed","family":"Kazmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Capucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John G.F.","family":"Cleland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew L.","family":"Clark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjcard.2019.08.018_bib0001","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1002\/ejhf.254","article-title":"Heart failure in patients with atrial fibrillation in Europe: a report from the EURObservational Research Programme Pilot survey on Atrial Fibrillation","volume":"17","author":"Lip","year":"2015","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.amjcard.2019.08.018_bib0002","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s10741-013-9409-4","article-title":"Atrial fibrillation and heart failure: intersecting populations, morbidities, and mortality","volume":"19","author":"Dickinson","year":"2014","journal-title":"Heart Fail Rev"},{"key":"10.1016\/j.amjcard.2019.08.018_bib0003","first-page":"264","article-title":"CHA2DS2-VASc risk factors as predictors of stroke after acute coronary syndrome: a systematic review and meta-analysis","volume":"7","author":"Guerra","year":"2018","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"key":"10.1016\/j.amjcard.2019.08.018_bib0004","doi-asserted-by":"crossref","first-page":"2920","DOI":"10.1161\/01.CIR.0000072767.89944.6E","article-title":"Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality: the Framingham Heart study","volume":"107","author":"Wang","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2019.08.018_bib0005","doi-asserted-by":"crossref","first-page":"2D","DOI":"10.1016\/S0002-9149(02)03373-8","article-title":"Atrial fibrillation in heart failure: epidemiology, pathophysiology, and rationale for therapy","volume":"91","author":"Maisel","year":"2003","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjcard.2019.08.018_bib0006","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.ejheart.2006.01.015","article-title":"Presence and development of atrial fibrillation in chronic heart failure. Experiences from the MERIT-HF Study","volume":"8","author":"van Veldhuisen","year":"2006","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.amjcard.2019.08.018_bib0007","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.ejheart.2006.10.021","article-title":"Atrial fibrillation in heart failure patients: prevalence in daily practice and effect on the severity of symptoms. Data from the ALPHA study registry","volume":"9","author":"De Ferrari","year":"2007","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.amjcard.2019.08.018_bib0008","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1093\/eurheartj\/ehi115","article-title":"Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS","volume":"26","author":"Flather","year":"2005","journal-title":"Eur Heart J"},{"key":"10.1016\/j.amjcard.2019.08.018_bib0009","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0140-6736(03)13800-7","article-title":"Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomised controlled trial","volume":"362","author":"Poole-Wilson","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.amjcard.2019.08.018_bib0010","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.ejheart.2006.08.004","article-title":"Prevalence and prognostic significance of atrial fibrillation in outpatients with heart failure due to left ventricular systolic dysfunction","volume":"9","author":"Corell","year":"2007","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.amjcard.2019.08.018_bib0011","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1016\/j.jacc.2006.01.060","article-title":"Atrial fibrillation and risk of clinical events in chronic heart failure with and without left ventricular systolic dysfunction: results from the Candesartan in Heart failure-Assessment of Reduction in Mortality and morbidity (CHARM) program","volume":"47","author":"Olsson","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2019.08.018_bib0012","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.ahj.2004.09.033","article-title":"Valsartan reduces the incidence of atrial fibrillation in patients with heart failure: results from the Valsartan Heart Failure Trial (Val-HeFT","volume":"149","author":"Maggioni","year":"2005","journal-title":"Am Heart J"},{"key":"10.1016\/j.amjcard.2019.08.018_bib0013","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/S0140-6736(03)14285-7","article-title":"Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial","volume":"362","author":"Yusuf","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.amjcard.2019.08.018_bib0014","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1002\/ejhf.813","article-title":"Epidemiology and one-year outcomes in patients with chronic heart failure and preserved, mid-range and reduced ejection fraction: an analysis of the ESC Heart Failure Long-Term Registry","volume":"19","author":"Chioncel","year":"2017","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.amjcard.2019.08.018_bib0015","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1161\/CIRCULATIONAHA.113.001475","article-title":"Temporal relationship and prognostic significance of atrial fibrillation in heart failure patients with preserved ejection fraction: a community-based study","volume":"128","author":"Zakeri","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2019.08.018_bib0016","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.hfc.2009.11.001","article-title":"Atrial fibrillation in congestive heart failure","volume":"6","author":"Lubitz","year":"2010","journal-title":"Heart Fail Clin"},{"key":"10.1016\/j.amjcard.2019.08.018_bib0017","doi-asserted-by":"crossref","first-page":"2539","DOI":"10.1093\/eurheartj\/ehm037","article-title":"How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology","volume":"28","author":"Paulus","year":"2007","journal-title":"Eur Heart J"},{"key":"10.1016\/j.amjcard.2019.08.018_bib0018","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1002\/ejhf.592","article-title":"Developed with the special contribution of the Heart Failure Association (HFA) of the ESC","volume":"18","author":"Ponikowski","year":"2016","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.amjcard.2019.08.018_bib0019","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1751-7133.2009.00114.x","article-title":"The atrial fibrillation paradox of heart failure","volume":"16","author":"Shelton","year":"2010","journal-title":"Congest Heart Fail"},{"key":"10.1016\/j.amjcard.2019.08.018_bib0020","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1161\/CIRCULATIONAHA.115.018614","article-title":"Atrial fibrillation begets heart failure and vice versa: temporal associations and differences in preserved versus reduced ejection fraction","volume":"133","author":"Santhanakrishnan","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2019.08.018_bib0021","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1161\/CIRCULATIONAHA.109.873265","article-title":"N-terminal pro-B-type natriuretic peptide is a major predictor of the development of atrial fibrillation: the cardiovascular health study","volume":"120","author":"Patton","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2019.08.018_bib0022","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1093\/europace\/euu175","article-title":"B-type natriuretic peptide and C-reactive protein in the prediction of atrial fibrillation risk: the CHARGE-AF Consortium of community-based cohort studies","volume":"16","author":"Sinner","year":"2014","journal-title":"Europace"},{"key":"10.1016\/j.amjcard.2019.08.018_bib0023","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1016\/j.jacc.2010.05.049","article-title":"Assessment of conventional cardiovascular risk factors and multiple biomarkers for the prediction of incident heart failure and atrial fibrillation","volume":"56","author":"Smith","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2019.08.018_bib0024","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1161\/CIRCULATIONAHA.110.007252","article-title":"Plasma B-type natriuretic peptide levels and recurrent arrhythmia after successful ablation of lone atrial fibrillation","volume":"123","author":"Hussein","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2019.08.018_bib0025","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1007\/s10557-015-6624-3","article-title":"Cardiac remodeling, circulating biomarkers and clinical events in patients with a history of atrial fibrillation. data from the GISSI-AF trial","volume":"29","author":"Staszewsky","year":"2015","journal-title":"Cardiovasc Drugs Ther"},{"key":"10.1016\/j.amjcard.2019.08.018_bib0026","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1093\/eurheartj\/ehu405","article-title":"Left atrial function measured by cardiac magnetic resonance imaging in patients with heart failure: clinical associations and prognostic value","volume":"36","author":"Pellicori","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.amjcard.2019.08.018_bib0027","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.112.005694","article-title":"Atrial fibrillation and outcomes in heart failure with preserved versus reduced left ventricular ejection fraction","volume":"2","author":"McManus","year":"2013","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.amjcard.2019.08.018_bib0028","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1002\/ejhf.187","article-title":"The prognostic significance of atrial fibrillation in heart failure with a preserved and reduced left ventricular function: insights from a meta-analysis","volume":"16","author":"Cheng","year":"2014","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.amjcard.2019.08.018_bib0029","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1093\/eurheartj\/ehv115","article-title":"Randomized trial of atrial arrhythmia monitoring to guide anticoagulation in patients with implanted defibrillator and cardiac resynchronization devices","volume":"36","author":"Martin","year":"2015","journal-title":"Eur Heart J"}],"container-title":["The American Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914919309610?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914919309610?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T06:31:07Z","timestamp":1757572267000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002914919309610"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":29,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["S0002914919309610"],"URL":"https:\/\/doi.org\/10.1016\/j.amjcard.2019.08.018","relation":{},"ISSN":["0002-9149"],"issn-type":[{"value":"0002-9149","type":"print"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prevalence and Incidence of Atrial Fibrillation in Ambulatory Patients With Heart Failure","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjcard.2019.08.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}